Vernalis Research - a Fully Owned Subsidiary of HitGen Inc - and Hannibal Innovation Announce the Creation of Dania Therapeutics ApS
Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Hannibal Innovation ApS ("Hannibal") are pleased to announce the creation of Dania Therapeutics ApS ("Dania") to discover
United States United Kingdom Kim Andersen Kristian Helin Kostenloser Wertpapierhandel Karin Absalonsen
Source: finanznachrichten.de